Stay updated with breaking news from Nasdaq Cntx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Context Therapeutics Inc. (NASDAQ:CNTX – Get Rating) was the target of a large growth in short interest in May. As of May 31st, there was short interest totalling 253,300 shares, a growth of 153.3% from the May 15th total of 100,000 shares. Approximately 1.7% of the company’s stock are short sold. Based on an average […]
Context Therapeutics Inc. (NASDAQ:CNTX – Get Rating) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 118,500 shares, an increase of 6.8% from the April 15th total of 111,000 shares. Based on an average trading volume of 115,300 shares, the short-interest ratio is […]
CTIM-76 IND filing on track for Q1 2024 Preclinical data on CLDN6 bispecific antibody CTIM-76 presented at AACR Annual Meeting 2023 Cash and cash...
Context Therapeutics Inc. (NASDAQ:CNTX – Get Rating) saw a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 111,000 shares, a growth of 19.5% from the March 31st total of 92,900 shares. Currently, 0.8% of the company’s shares are sold short. Based on an average […]
Context Therapeutics Inc. (NASDAQ:CNTX – Get Rating) saw a significant drop in short interest in the month of March. As of March 31st, there was short interest totalling 92,900 shares, a drop of 54.6% from the March 15th total of 204,800 shares. Currently, 0.7% of the company’s stock are short sold. Based on an average […]